STUDY OBJECTIVES: Childhood obstructive sleep apnea syndrome (OSAS) is associated with an elevation of inflammatory markers such as C-reactive protein (CRP) that correlates with specific morbidities and subsides following intervention. In adults, OSAS is associated with activation of the transcription factor nuclear factor kappa B (NF-kB). We explored the mechanisms underlying NF-kB activation, based on the hypothesis that specific NF-kB signaling is activated in children with OSAS. DESIGN: Adenoid and tonsillar tissues from children with OSAS and matched controls were immunostained against NF-kB classical (p65 and p50) and alternative (RelB and p52) pathway subunits, and NF-kB-dependent cytokines: interleukin (IL)- 1α, IL-1β, tumor necrosis factor-α, and IL-8). Serum CRP levels were measured in all subjects. NF-kB induction was evaluated by a luciferase-NF-kB reporter assay in L428 cells constitutively expressing NF-kB and in Jurkat cells with inducible NF-kB expression. p65 translocation to the nucleus, reflecting NF-kB activation, was measured in cells expressing fluorescent NF-kB-p65-GFP (green fluorescent protein). SETTING: Sleep research laboratory. PATIENTS OR PARTICIPANTS: Twenty-five children with OSAS and 24 without OSAS. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Higher expression of IL-1α and classical NF-kB subunits p65 and p50 was observed in adenoids and tonsils of children with OSAS. Patient serum induced NF-kB activity, as measured by a luciferase-NF-kB reporter assay and by induction of p65 nuclear translocation in cells permanently transfected with GFP-p65 plasmid. IL-1β showed increased epithelial expression in OSAS tissues. CONCLUSIONS: Nuclear factor kappa B is locally and systemically activated in children with obstructive sleep apnea syndrome. This observation may motivate the search for new anti-inflammatory strategies for controlling nuclear factor kappa B activation in obstructive sleep apnea syndrome.
STUDY OBJECTIVES:Childhood obstructive sleep apnea syndrome (OSAS) is associated with an elevation of inflammatory markers such as C-reactive protein (CRP) that correlates with specific morbidities and subsides following intervention. In adults, OSAS is associated with activation of the transcription factor nuclear factor kappa B (NF-kB). We explored the mechanisms underlying NF-kB activation, based on the hypothesis that specific NF-kB signaling is activated in children with OSAS. DESIGN: Adenoid and tonsillar tissues from children with OSAS and matched controls were immunostained against NF-kB classical (p65 and p50) and alternative (RelB and p52) pathway subunits, and NF-kB-dependent cytokines: interleukin (IL)- 1α, IL-1β, tumor necrosis factor-α, and IL-8). Serum CRP levels were measured in all subjects. NF-kB induction was evaluated by a luciferase-NF-kB reporter assay in L428 cells constitutively expressing NF-kB and in Jurkat cells with inducible NF-kB expression. p65 translocation to the nucleus, reflecting NF-kB activation, was measured in cells expressing fluorescent NF-kB-p65-GFP (green fluorescent protein). SETTING: Sleep research laboratory. PATIENTS OR PARTICIPANTS: Twenty-five children with OSAS and 24 without OSAS. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Higher expression of IL-1α and classical NF-kB subunits p65 and p50 was observed in adenoids and tonsils of children with OSAS. Patient serum induced NF-kB activity, as measured by a luciferase-NF-kB reporter assay and by induction of p65 nuclear translocation in cells permanently transfected with GFP-p65 plasmid. IL-1β showed increased epithelial expression in OSAS tissues. CONCLUSIONS: Nuclear factor kappa B is locally and systemically activated in children with obstructive sleep apnea syndrome. This observation may motivate the search for new anti-inflammatory strategies for controlling nuclear factor kappa B activation in obstructive sleep apnea syndrome.
Authors: R T Brouillette; J J Manoukian; F M Ducharme; K Oudjhane; L G Earle; S Ladan; A Morielli Journal: J Pediatr Date: 2001-06 Impact factor: 4.406
Authors: Raouf S Amin; Thomas R Kimball; Judy A Bean; Jenny L Jeffries; J Paul Willging; Robin T Cotton; Sandra A Witt; Betty J Glascock; Steven R Daniels Journal: Am J Respir Crit Care Med Date: 2002-05-15 Impact factor: 21.405
Authors: Ronald D Chervin; Kristen Hedger Archbold; James E Dillon; Parviz Panahi; Kenneth J Pituch; Ronald E Dahl; Christian Guilleminault Journal: Pediatrics Date: 2002-03 Impact factor: 7.124
Authors: Aviv D Goldbart; Julie L Goldman; Richard C Li; Kenneth R Brittian; Riva Tauman; David Gozal Journal: Chest Date: 2004-07 Impact factor: 9.410
Authors: Wioletta Olejarz; Alicja Głuszko; Agata Cyran; Katarzyna Bednarek-Rajewska; Robert Proczka; David F Smith; Stacey L Ishman; Ewa Migacz; Wojciech Kukwa Journal: Sleep Breath Date: 2020-02-20 Impact factor: 2.816